Amarantus Bioscience Holdings Inc (AMBS) Financial Statements (2023 and Earlier)

Company Profile

Business Address 655 MONTGOMERY STREET
SAN FRANCISCO, CA 94111
State of Incorp. NV
Fiscal Year End December 31
Industry (SIC) 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

12/31/2015
12/31/2014
12/31/2013
12/31/2012
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments1762141,033157
Cash and cash equivalents1762141,033157
Prepaid expense and other current assets520
Other undisclosed current assets652198215 
Total current assets:8284121,248677
Noncurrent Assets
Property, plant and equipment115145  
Intangible assets, net (including goodwill), including:2,8611,497611
Goodwill7,967   
Intangible assets, net (excluding goodwill)2,8611,497611 
Other undisclosed intangible assets, net (including goodwill)(7,967) 
Other undisclosed noncurrent assets7,967204 533
Total noncurrent assets:10,9431,846611533
TOTAL ASSETS:11,7712,2581,8591,210
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:7,7233,5271,2642,597
Accounts payable 3,3539712,597
Accrued liabilities 149292 
Interest and dividends payable19525  
Other undisclosed accounts payable and accrued liabilities7,528   
Debt1,000 932740
Derivative instruments and hedges, liabilities5,098 5,85927
Due to related parties257252248222
Other undisclosed current liabilities2,1142,5502371,152
Total current liabilities:16,1926,3298,5394,738
Noncurrent Liabilities
Other undisclosed noncurrent liabilities1,113   
Total noncurrent liabilities:1,113   
Total liabilities:17,3056,3298,5394,738
Temporary equity, carrying amount3,154   
Stockholders' equity
Stockholders' equity attributable to parent, including:(8,688)(4,071)(7,519)(3,528)
Common stock21842574343
Additional paid in capital74,76745,05018,9387,991
Accumulated deficit(92,241)(55,183)  
Other undisclosed stockholders' equity attributable to parent8,7655,220(27,031)(11,862)
Other undisclosed stockholders' equity  839 
Total stockholders' equity:(8,688)(4,071)(6,680)(3,528)
TOTAL LIABILITIES AND EQUITY:11,7712,2581,8591,210

Income Statement (P&L) ($ in thousands)

12/31/2015
12/31/2014
12/31/2013
12/31/2012
Operating expenses(24,821)(21,354)(5,711)(4,096)
Other operating expense, net
(Other Expenses)
 (9)  
Other undisclosed operating income (loss) 9 (1,039)
Operating loss:(24,821)(21,354)(5,711)(5,136)
Nonoperating income (expense)(393)(5,923)(9,421)485
Investment income, nonoperating4,105317271485
Interest and debt expense(1,296)(2,063)(9,340) 
Loss from continuing operations before equity method investments, income taxes:(26,510)(29,340)(24,471)(4,651)
Other undisclosed income from continuing operations before income taxes1,2972,0629,341 
Loss before gain (loss) on sale of properties:(25,213)(27,278)(15,131)(4,651)
Other undisclosed net income   560
Net loss:(25,213)(27,278)(15,131)(4,090)
Other undisclosed net income (loss) attributable to parent(1)1(1)(1,045)
Net loss attributable to parent:(25,214)(27,277)(15,132)(5,136)
Preferred stock dividends and other adjustments(3,595)(875)(38) 
Other undisclosed net loss available to common stockholders, basic(8,249)   
Net loss available to common stockholders, basic:(37,058)(28,152)(15,170)(5,136)
Convertible preferred dividends(8,249)   
Net loss available to common stockholders, diluted:(45,307)(28,152)(15,170)(5,136)

Comprehensive Income ($ in thousands)

12/31/2015
12/31/2014
12/31/2013
12/31/2012
Net loss:(25,213)(27,278)(15,131)(4,090)
Comprehensive loss, net of tax, attributable to parent:(25,213)(27,278)(15,131)(4,090)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: